Brokered financing will include series CC and series DD warrants
By Devika Patel
Knoxville, Tenn., Nov. 8 - Neoprobe Corp. said it plans a registered direct offering of stock. Rodman & Renshaw, LLC is the agent.
The company will sell about 3.2 million common shares at $1.90 apiece for $6 million. The price per share represents a 11.22% discount to the Nov. 5 closing share price of $2.14.
The investors will also receive two warrants, which are each exercisable at $2.11. The strike price is a 1.4% discount to the Nov. 5 closing share price.
The series CC warrants will be exercisable for about 1.6 million shares for one year. The series DD warrants, also exercisable for about 1.6 million shares, will be exercisable for two years.
Settlement is expected Nov. 11.
Proceeds will be used for general corporate purposes.
"We are pleased to be able to raise capital with strong support from institutional investors at market pricing," president and chief executive David Bupp said in a press release.
"The incremental capital will assist the company in moving forward as we finalize our development of Lymphoseek and our initial development activities for the RIGScan technology.
"The nature of the warrants provides a near-term source of additional development capital. The capital also provides us with the opportunity to pursue our stated objective of obtaining a listing on one of the major exchanges," Bupp stated.
Neoprobe is a Dublin, Ohio-based biomedical company focused on improving cancer surgery outcomes.
| Issuer: | Neoprobe Corp.
|
| Issue: | Common shares
|
| Amount: | $6 million
|
| Shares: | 3.2 million (approximate)
|
| Price: | $1.90
|
| Warrants: | For about 3.2 million shares
|
| Warrant expiration: | One year (series CC), two years (series DD)
|
| Warrant strike price: | $2.11
|
| Agent: | Rodman & Renshaw, LLC
|
| Pricing date: | Nov. 8
|
| Settlement date: | Nov. 11
|
| Stock symbol: | OTCBB: NEOP
|
| Stock price: | $2.14 at close Nov. 5
|
| Market capitalization: | $143.99 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
